412 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Stratos Investment Management LLC

Stratos Investment Management LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 412 shares of the medical equipment provider’s stock, valued at approximately $215,000.

Other large investors have also added to or reduced their stakes in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter worth about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $590.90 on Thursday. The firm’s 50 day simple moving average is $551.99 and its 200 day simple moving average is $512.04. The company has a market capitalization of $210.47 billion, a P/E ratio of 92.18, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 28,843 shares of company stock valued at $15,357,560. 0.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.